• Clinical Evidence

Evaluation of Glycemic Control with EndoTool Glucose Management System for Insulin Infusion Therapy

Setting: 371-bed full-service community medical center.

Objective

This retrospective review compares glycemic control with EndoTool to a traditional insulin infusion protocol for critically-ill patients.

Setting

371-bed full-service community medical center.

Results

  • Median time to control (first recorded blood glucose <150 mg/dL) decreased 30.9% with EndoTool, from 7 hours 50 minutes to 5 hours 25 minutes.
  • Time in the target range of 100-150 mg/dL mg/dL increased 19.0% with EndoTool, from 50.6% to 60.2%.
  • Incidence of hypoglycemia <70 mg/dL decreased 70.3% with EndoTool, from 41.4% to 12.3% of patients.
  • Incidence of hypoglycemia <50 mg/dL decreased 84.7% with EndoTool, from 26.8% to 4.1% of patients.
  • Median ICU length of stay decreased by 2 full days with EndoTool, from 6 days to 4 days.
  • Median hospital length of stay decreased by 4 full days with EndoTool, from 12 days to 8 days.

Conclusions

EndoTool should be the standard of care for management of patients receiving continuous infusion insulin, given its ability to achieve significant reductions in time to control, hypoglycemia and length of stay as well as a greater percent of time in the target blood glucose range.

Objective

This retrospective review compares glycemic control with EndoTool to a traditional insulin infusion protocol for critically-ill patients.

Setting

371-bed full-service community medical center.

Results
  • Median time to control (first recorded blood glucose <150 mg/dL) decreased 30.9% with EndoTool, from 7 hours 50 minutes to 5 hours 25 minutes.
  • Time in the target range of 100-150 mg/dL mg/dL increased 19.0% with EndoTool, from 50.6% to 60.2%.
  • Incidence of hypoglycemia <70 mg/dL decreased 70.3% with EndoTool, from 41.4% to 12.3% of patients.
  • Incidence of hypoglycemia <50 mg/dL decreased 84.7% with EndoTool, from 26.8% to 4.1% of patients.
  • Median ICU length of stay decreased by 2 full days with EndoTool, from 6 days to 4 days.
  • Median hospital length of stay decreased by 4 full days with EndoTool, from 12 days to 8 days.
Conclusions

EndoTool should be the standard of care for management of patients receiving continuous infusion insulin, given its ability to achieve significant reductions in time to control, hypoglycemia and length of stay as well as a greater percent of time in the target blood glucose range.

References

Authors

Lauren Igneri, PharmD, BCPS, BCCCP; Alan Schorr, DO, FAAIM, FACE; Patricia Gilbert, MSN, RN; Katherine Krol, BSN, CCRN; Brandon Kim, PharmD; Jessica Ellis, PharmD; Suzette Cunicelli, RPh; Benjamin Solomon, MD.

Source

Presented at American College of Clinical Pharmacy Global Conference and Society of Critical Care Medicine Critical Care Congress. Published in Journal of the American College of Clinical Pharmacy, Volume 1, Issue 2, p122-353 and Critical Care Medicine, Volume 44, Issue 12, p197.

Year

2018

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective review compares glycemic control with EndoTool to a traditional insulin infusion protocol for critically-ill patients.

Setting

371-bed full-service community medical center.

Results
  • Median time to control (first recorded blood glucose <150 mg/dL) decreased 30.9% with EndoTool, from 7 hours 50 minutes to 5 hours 25 minutes.
  • Time in the target range of 100-150 mg/dL mg/dL increased 19.0% with EndoTool, from 50.6% to 60.2%.
  • Incidence of hypoglycemia <70 mg/dL decreased 70.3% with EndoTool, from 41.4% to 12.3% of patients.
  • Incidence of hypoglycemia <50 mg/dL decreased 84.7% with EndoTool, from 26.8% to 4.1% of patients.
  • Median ICU length of stay decreased by 2 full days with EndoTool, from 6 days to 4 days.
  • Median hospital length of stay decreased by 4 full days with EndoTool, from 12 days to 8 days.
Conclusions

EndoTool should be the standard of care for management of patients receiving continuous infusion insulin, given its ability to achieve significant reductions in time to control, hypoglycemia and length of stay as well as a greater percent of time in the target blood glucose range.

References

Authors

Lauren Igneri, PharmD, BCPS, BCCCP; Alan Schorr, DO, FAAIM, FACE; Patricia Gilbert, MSN, RN; Katherine Krol, BSN, CCRN; Brandon Kim, PharmD; Jessica Ellis, PharmD; Suzette Cunicelli, RPh; Benjamin Solomon, MD.

Source

Presented at American College of Clinical Pharmacy Global Conference and Society of Critical Care Medicine Critical Care Congress. Published in Journal of the American College of Clinical Pharmacy, Volume 1, Issue 2, p122-353 and Critical Care Medicine, Volume 44, Issue 12, p197.

Year

2018

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.